Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

520 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development.
Williams MS, Weiss EJ, Sabatine MS, Simon DI, Bahou WF, Becker LC, Parise LV, Dauerman HL, French PA, Smyth SS, Becker RC; 2010 Platelet Colloquium Participants. Williams MS, et al. Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2372-84. doi: 10.1161/ATVBAHA.110.218131. Arterioscler Thromb Vasc Biol. 2010. PMID: 21084706 Free PMC article. Review.
Genetics of arterial prothrombotic risk states.
Williams MS, Bray PF. Williams MS, et al. Exp Biol Med (Maywood). 2001 May;226(5):409-19. doi: 10.1177/153537020122600504. Exp Biol Med (Maywood). 2001. PMID: 11393168 Review.
Center Variation in Use of Preoperative Dual Antiplatelet Therapy and Platelet Function Testing at the Time of Coronary Artery Bypass Grafting in Maryland.
Hensley NB, Ariyo PT, Holmes SD, Williams MS, Joseph Robert Whitman G, Ad N, Metkus TS; Maryland Cardiac Surgical Quality Initiative. Hensley NB, et al. Among authors: williams ms. Anesth Analg. 2022 Sep 1;135(3):567-575. doi: 10.1213/ANE.0000000000005964. Epub 2022 Apr 15. Anesth Analg. 2022. PMID: 35426835
Effect of Evolocumab on Atherogenic Lipoproteins During the Peri- and Early Postinfarction Period: A Placebo-Controlled, Randomized Trial.
Leucker TM, Blaha MJ, Jones SR, Vavuranakis MA, Williams MS, Lai H, Schindler TH, Latina J, Schulman SP, Gerstenblith G. Leucker TM, et al. Among authors: williams ms. Circulation. 2020 Jul 28;142(4):419-421. doi: 10.1161/CIRCULATIONAHA.120.046320. Epub 2020 Jul 27. Circulation. 2020. PMID: 32718248 Free PMC article. Clinical Trial. No abstract available.
Platelet activation and endothelial dysfunction biomarkers in acute coronary syndrome: the impact of PCSK9 inhibition.
Ziogos E, Chelko SP, Harb T, Engel M, Vavuranakis MA, Landim-Vieira M, Walsh EM, Williams MS, Lai S, Halushka MK, Gerstenblith G, Leucker TM. Ziogos E, et al. Among authors: williams ms. Eur Heart J Cardiovasc Pharmacother. 2023 Nov 2;9(7):636-646. doi: 10.1093/ehjcvp/pvad051. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 37468450 Clinical Trial.
The Trajectory of Lipoprotein(a) During the Peri- and Early Postinfarction Period and the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition.
Vavuranakis MA, Jones SR, Ziogos E, Blaha MJ, Williams MS, Foran P, Schindler TH, Lai S, Schulman SP, Gerstenblith G, Leucker TM. Vavuranakis MA, et al. Among authors: williams ms. Am J Cardiol. 2022 May 15;171:1-6. doi: 10.1016/j.amjcard.2022.01.058. Epub 2022 Mar 21. Am J Cardiol. 2022. PMID: 35314069
Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized Trial.
Leucker TM, Osburn WO, Reventun P, Smith K, Claggett B, Kirwan BA, de Brouwer S, Williams MS, Gerstenblith G, Hager DN, Streiff MB, Solomon SD, Lowenstein CJ. Leucker TM, et al. Among authors: williams ms. JACC Basic Transl Sci. 2021 Dec;6(12):935-945. doi: 10.1016/j.jacbts.2021.09.013. Epub 2021 Dec 8. JACC Basic Transl Sci. 2021. PMID: 34904132 Free PMC article.
520 results